-
1
Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression
Published 2024-12-01Subjects: “…HER-2 overexpression…”
Get full text
Article -
2
Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction
Published 2024-12-01Subjects: “…HER2-overexpressing cancers…”
Get full text
Article